Skip to main content
Erschienen in: Cancer Causes & Control 1/2012

01.01.2012 | Original paper

Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study

verfasst von: Clare Kahn, Leonardo Simonella, Mark Sywak, Steven Boyages, Owen Ung, Dianne O’Connell

Erschienen in: Cancer Causes & Control | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Over the past few decades, an increase in the incidence of thyroid cancer has been recorded in many countries around the world including Australia. Heightened medical surveillance and increased technological sensitivity could be contributing to greater detection of asymptomatic disease.

Objectives

To describe the pathways to diagnosis of thyroid cancer for a cohort of newly diagnosed patients in New South Wales (NSW), Australia, and compare these pathways by age, sex, place of residence, ethnic background, medical insurance status, and disease characteristics.

Methods

A total of 452 newly diagnosed cases of thyroid cancer were recruited through the population-based NSW Central Cancer Registry. Participants completed a questionnaire and diary of doctor visits and investigations that led to their diagnosis. Tumor characteristics were obtained from pathology reports.

Results

Forty percent of patients initially presented to their doctor with a lump or symptom specific to thyroid cancer and 60% had their cancer detected incidentally during a medical encounter. Men were more likely than women to be diagnosed after imaging for another health concern versus reporting a thyroid lump or symptom (p = 0.001). Thyroid cancer diagnosis after imaging for another health concern increased with age (p = 0.023), and larger tumors were less likely to be diagnosed after treatment for a benign thyroid disease (p = 0.040).

Conclusion

As the majority of participants had incidental diagnoses, the reported incidence of thyroid cancer is likely to be influenced by diagnostic technology and medical surveillance practices. This, however, probably only partly explains the observed rise in the incidence of thyroid cancer in NSW.
Literatur
1.
Zurück zum Zitat Burgess JR (2002) Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12(2):141–149PubMedCrossRef Burgess JR (2002) Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12(2):141–149PubMedCrossRef
2.
Zurück zum Zitat Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16):3801–3807PubMedCrossRef Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115(16):3801–3807PubMedCrossRef
3.
Zurück zum Zitat Colonna M, Grosclaude P, Remontet L et al (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 38(13):1762–1768PubMedCrossRef Colonna M, Grosclaude P, Remontet L et al (2002) Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer 38(13):1762–1768PubMedCrossRef
4.
Zurück zum Zitat Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295(18):2164–2167PubMedCrossRef
5.
Zurück zum Zitat Kilfoy BA, Zheng T, Holford TR et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCrossRef Kilfoy BA, Zheng T, Holford TR et al (2009) International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5):525–531PubMedCrossRef
6.
Zurück zum Zitat Colonna M, Guizard AV, Schvartz C et al (2007) A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer 43(5):891–900PubMedCrossRef Colonna M, Guizard AV, Schvartz C et al (2007) A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer 43(5):891–900PubMedCrossRef
7.
Zurück zum Zitat Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060PubMedCrossRef Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060PubMedCrossRef
8.
Zurück zum Zitat Verkooijen HM, Fioretta G, Pache J-C et al (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17PubMedCrossRef Verkooijen HM, Fioretta G, Pache J-C et al (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17PubMedCrossRef
9.
Zurück zum Zitat Kovacs GL, Gonda G, Vadasz G et al (2005) Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15(2):152–157PubMedCrossRef Kovacs GL, Gonda G, Vadasz G et al (2005) Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15(2):152–157PubMedCrossRef
10.
11.
Zurück zum Zitat Kent WDT, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA (2007) Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 177(11):1357–1361PubMedCrossRef Kent WDT, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA (2007) Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 177(11):1357–1361PubMedCrossRef
12.
Zurück zum Zitat Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, Capesius C (2006) Thyroid cancer in Luxembourg: a national population-based data report (1983–1999). BMC Cancer 6:102PubMedCrossRef Scheiden R, Keipes M, Bock C, Dippel W, Kieffer N, Capesius C (2006) Thyroid cancer in Luxembourg: a national population-based data report (1983–1999). BMC Cancer 6:102PubMedCrossRef
13.
Zurück zum Zitat Yu GP, Li JC, Branovan D, McCormick S, Schantz SP (2010) Thyroid cancer incidence and survival in the National Cancer Institute Surveillance, Epidemiology, and End Results race/ethnicity groups. Thyroid 20:465–473PubMedCrossRef Yu GP, Li JC, Branovan D, McCormick S, Schantz SP (2010) Thyroid cancer incidence and survival in the National Cancer Institute Surveillance, Epidemiology, and End Results race/ethnicity groups. Thyroid 20:465–473PubMedCrossRef
14.
Zurück zum Zitat Zhu C, Zheng T, Kilfoy BA et al (2009) A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004. Thyroid 19(10):1061–1066PubMedCrossRef Zhu C, Zheng T, Kilfoy BA et al (2009) A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973–2004. Thyroid 19(10):1061–1066PubMedCrossRef
15.
Zurück zum Zitat Ward EM, Jemal A, Chen A (2010) Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Fut Oncol 6:185–188CrossRef Ward EM, Jemal A, Chen A (2010) Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Fut Oncol 6:185–188CrossRef
16.
Zurück zum Zitat Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791PubMedCrossRef Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18(3):784–791PubMedCrossRef
17.
Zurück zum Zitat Preston-Martin S, Franceschi S, Ron E, Negri E (2003) Thyroid cancer pooled analysis from 14 case–control studies: what have we learned? Cancer Causes Control 14:787–789PubMedCrossRef Preston-Martin S, Franceschi S, Ron E, Negri E (2003) Thyroid cancer pooled analysis from 14 case–control studies: what have we learned? Cancer Causes Control 14:787–789PubMedCrossRef
18.
Zurück zum Zitat Zivaljevic V, Vlajinac H, Jankovic R et al (2003) Case–control study of female thyroid cancer—menstrual, reproductive and hormonal factors. Eur J Cancer Prev 12:63–66PubMedCrossRef Zivaljevic V, Vlajinac H, Jankovic R et al (2003) Case–control study of female thyroid cancer—menstrual, reproductive and hormonal factors. Eur J Cancer Prev 12:63–66PubMedCrossRef
19.
Zurück zum Zitat Dal ML, Bosetti C, La VC, Franceschi S (2009) Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20:75–86CrossRef Dal ML, Bosetti C, La VC, Franceschi S (2009) Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20:75–86CrossRef
20.
Zurück zum Zitat Stavrou E, Baker D, McElroy H, Bishop J (2008) Thyroid cancer in New South Wales. Cancer Institute NSW, Sydney Stavrou E, Baker D, McElroy H, Bishop J (2008) Thyroid cancer in New South Wales. Cancer Institute NSW, Sydney
21.
Zurück zum Zitat Tracey EA, Supramaniam R, Chen W (2003) Cancer in New South Wales: incidence and mortality 2001. The Cancer Council NSW, Sydney Tracey EA, Supramaniam R, Chen W (2003) Cancer in New South Wales: incidence and mortality 2001. The Cancer Council NSW, Sydney
22.
Zurück zum Zitat Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK (2007) Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol 20:2560–2566CrossRef Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK (2007) Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol 20:2560–2566CrossRef
23.
Zurück zum Zitat Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28:964–974PubMedCrossRef Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28:964–974PubMedCrossRef
24.
Zurück zum Zitat New South Wales Central Cancer Registry (1986) Cancer in New South Wales: incidence and mortality 1980. Department of Health NSW, Sydney New South Wales Central Cancer Registry (1986) Cancer in New South Wales: incidence and mortality 1980. Department of Health NSW, Sydney
25.
Zurück zum Zitat Tracey E, Alam N, Chen W, Bishop J (2008) Cancer in New South Wales: incidence and mortality 2006. Cancer Institute NSW, Sydney Tracey E, Alam N, Chen W, Bishop J (2008) Cancer in New South Wales: incidence and mortality 2006. Cancer Institute NSW, Sydney
26.
Zurück zum Zitat Burgess JR, Tucker P (2006) Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16(1):47–53PubMedCrossRef Burgess JR, Tucker P (2006) Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16(1):47–53PubMedCrossRef
27.
Zurück zum Zitat Leennhardt L, Bernier MO, Boin-Pineau MH et al (2004) Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 150(2):133–139CrossRef Leennhardt L, Bernier MO, Boin-Pineau MH et al (2004) Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 150(2):133–139CrossRef
28.
Zurück zum Zitat Hall SF, Walker H, Siemens R, Schneeberg A (2009) Increasing detection and increasing incidence in thyroid cancer. World J Surg 33(12):2567–2571PubMedCrossRef Hall SF, Walker H, Siemens R, Schneeberg A (2009) Increasing detection and increasing incidence in thyroid cancer. World J Surg 33(12):2567–2571PubMedCrossRef
29.
Zurück zum Zitat Li M, Eastman CJ, Waite KV et al (2006) Are Australian children iodine deficient? Results of the Australian National Iodine Nutrition Study. Med J Aust 184:165–169PubMed Li M, Eastman CJ, Waite KV et al (2006) Are Australian children iodine deficient? Results of the Australian National Iodine Nutrition Study. Med J Aust 184:165–169PubMed
30.
Zurück zum Zitat Grodski S, Brown T, Sidhu S et al (2008) Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144(6):1038–1043PubMedCrossRef Grodski S, Brown T, Sidhu S et al (2008) Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144(6):1038–1043PubMedCrossRef
Metadaten
Titel
Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study
verfasst von
Clare Kahn
Leonardo Simonella
Mark Sywak
Steven Boyages
Owen Ung
Dianne O’Connell
Publikationsdatum
01.01.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 1/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9852-2

Weitere Artikel der Ausgabe 1/2012

Cancer Causes & Control 1/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.